The Democratic Republic of Congo will assess lenders’ requests for exemptions from rules requiring them to diversify their ownership, central bank Governor Andre Wameso said.

President Donald Trump said the US is working with Belarus to secure more supplies of potash amid a trade fight with Canada, a major supplier of the critical ingredient used in fertilizers.

Turkey is considering to establish a pool of assets from funds frozen by regulators following defaults that sparked investor ...

A county board in North Carolina is set to vote on a proposed merger between WakeMed Health and Hospitals, a regional health system serving the Raleigh area, and Atrium Health, one of the largest ...

Amazon.com Inc. has blocked Meta Platforms Inc.’s new artificial intelligence agent from its retail site after the social media company declined a request to remove the bot.

Vladimir Putin is set to travel to China for the Asia-Pacific Economic Cooperation summit hosted by President Xi Jinping but is likely to skip the Group of 20 in the US with Donald Trump.

Bank of Canada Governor Tiff Macklem said policymakers don't want to be late to hike interest rates should inflationary pressures prove more stubborn.

Carlyle Group Inc.-backed mobile services business Syniverse Technologies is working with Jefferies Financial Group Inc. to adjust the terms and extend the maturity of its existing debt, according to ...

In their quest to block a $72 billion merger between two of the biggest US freight railroads, a coalition of shippers and labor unions is trying to get President Donald Trump on their side.

A group of Swiss lobby organizations called on the country’s lawmakers to adopt the least burdensome proposal for new capital requirements on UBS Group AG, adding their voices to a similar push by the ...

Italian bottle-cap maker Tapí Group is being circled by industry rivals, with two bids submitted and a third in the works, even as private lender Tikehau Capital tries to take control of the ailing ...

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, is seeking to raise as much as $371.9 million in a US initial public offering.